Shotaro Kawano
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study.
Journal: Arthritis research & therapy
Published: June 18, 2025
Garcin Syndrome in a Patient with Hypertrophic Pachymeningitis Following Otitis Media with Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis (OMAAV).
Journal: Internal medicine (Tokyo, Japan)
Published: November 10, 2024
Treatment selection in the clinical practice of systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Journal: Modern rheumatology
Published: April 02, 2024
Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: December 08, 2022
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study.
Journal: Modern rheumatology
Published: February 18, 2022
Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.
Journal: Modern rheumatology case reports
Published: December 01, 2021
Increased Proportion of CD226+ B Cells Is Associated With the Disease Activity and Prognosis of Systemic Lupus Erythematosus.
Journal: Frontiers in immunology
Published: May 22, 2021
TNFR2 Signaling Enhances Suppressive Abilities of Human Circulating T Follicular Regulatory Cells.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 07, 2021
Last Updated: 09/26/2026